High-dose chemotherapy regimen well tolerated in breast cancer

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1320, 2002-01, pp. : 14-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High-Dose Chemotherapy in Breast Cancer

By Lake Diana E. Hudis Clifford A.

Drugs, Vol. 64, Iss. 17, 2004-01 ,pp. : 1851-1860

Adis International

Access to resources Recommend Favorite

Ibritumomab tiuxetan Y-90 plus high-dose BEAM chemotherapy was well tolerated in older patients with non-Hodgkin's lymphoma

Inpharma, Vol. 1, Iss. 1617, 2007-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Lower costs with sequential high-dose chemotherapy in breast cancer

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 422, 2003-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Biweekly paclitaxel plus gemcitabine is a highly active and well tolerated regimen in women with advanced breast cancer

Inpharma, Vol. 1, Iss. 1427, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

High-Dose Chemotherapy and Stem Cell Support for Breast Cancer: Where Are We Now?

By Gerrero R.M. Stein S. Stadtmauer E.A.

Drugs & Aging, Vol. 19, Iss. 7, 2002-01 ,pp. : 475-485

Adis International

Access to resources Recommend Favorite